Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany

Karsten Weller(Humboldt-Universität zu Berlin), Petra Staubach(Johannes Gutenberg University Mainz), Nicola Wagner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bettina Wedi(Medizinische Hochschule Hannover), Thomas Kramps(Novartis (Germany)), Andrea Bauer(University Hospital Carl Gustav Carus), Daniel Baeumer(Novartis (Germany)), Sibylle Schliemann(Jena University Hospital), Jan Multmeier(Total (Germany)), Marcus Maurer(Humboldt-Universität zu Berlin), Elena Hillmann(Novartis (Germany))
Journal of the European Academy of Dermatology and Venereology
October 9, 2021
10.1111/jdv.17724
Cited by 65

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|429
Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
|Journal of Allergy and Clinical Immunology|2014|419